Visualitza per autor "Iborra, Marisa"
Ara mostrant els elements 1-5 d 5
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Calafat, Margalida; Torres, Paola; Tosca Cuquerella, Joan; Sánchez Aldehuelo, Rubén; Rivero, Montserrat; Iborra, Marisa; Monfort, David (Sage, 2024-01-05) -
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Calafat, Margalida; Torres, Paola; Morales Alvarado, Víctor Jair; Tosca Cuquerella, Joan; Sánchez Aldehuelo, Rubén; Rivero, Montserrat; Iborra, Marisa (Sage, 2024-01-05) -
Effectiveness and safety of ustekinumab in bio-naïve Crohn’s disease patients: a multicentre observational retrospective study
Valdés Delgado, Teresa; Olmedo-Martín, Raúl Vicente; Herrera de Guise, Claudia Maria; Fuentes-Valenzuela, Esteban; Melcarne, Luigi; Iborra, Marisa (SAGE Publications, 2023) -
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Garre, Ana; Iborra, Marisa; Sierra-Ausín, Mónica; Barreiro de Acosta, Manuel; Fernández Clotet, Agnès; Monfort Miquel, David; PIQUERAS CANO, MARTA; Chaparro, María (Oxford University Press, 2021-11-08) -
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Aterido Ballonga, Adria; Guerra, Iván; Cabriada, Jose Luis; Marsal Barril, Sara; Julia Cano, Antonio; Chaparro, María; Bujanda, Luis; Iborra, Marisa (SAGE Publications, 2019-09-25)